[Skip to Navigation]
Sign In
Views 359
Citations 0
Correction
February 2020

Missing Panels in Figure 1

JAMA Oncol. 2020;6(2):302. doi:10.1001/jamaoncol.2019.6910

In the Original Investigation titled “Idelalisib for Treatment of Relapsed Follicular Lymphoma and Chronic Lymphocytic Leukemia: A Comparison of Treatment Outcomes in Clinical Trial Participants vs Medicare Beneficiaries,”1 there was an error in Figure 1. Two panels were missing from the previous Figure that presented persistency among the 2 cohorts. A new Figure with the missing parts appears in print and this article was corrected online.

References
1.
Bird  ST, Tian  F, Flowers  N,  et al.  Idelalisib for treatment of relapsed follicular lymphoma and chronic lymphocytic leukemia: a comparison of treatment outcomes in clinical trial participants vs Medicare beneficiaries [published online December 19, 2019].  JAMA Oncol. doi:10.1001/jamaoncol.2019.3994PubMedGoogle Scholar
×